First AD

Second AD

Precision Medicine in Oncology®

The OncLive Precision Medicine in Oncology® condition center page is a comprehensive resource for clinical news and expert insights on precision-focused approaches in patients with cancer, with gene-targeted tyrosine kinase inhibitors and antibody-drug conjugates, checkpoint inhibitors, tumor-infiltrating lymphocyte therapy, and other tailored treatments. This page features news articles, interviews in written and video format, and podcasts that focus on updates and ongoing research with personalized therapies across solid and hematologic tumors.

Special Reports in Personalized Cancer Care

The OncLive Special Reports in Personalized Cancer Care condition center is a comprehensive resource for clinical news and expert insights on personalized  treatment in lung cancer, breast cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, gynecologic cancers, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research as it relates to precision oncology therapeutics. 

TRK Inhibitors: Precision Medicine in Oncology

Peer Exchange

Genomic Profiling in Solid Tumor Malignancies: Challenges

Precision Medicine in Solid Tumor Malignancies

Significance of TRK Inhibitors for Solid Tumors

Precision Medicine for Solid Tumors: Where We Are Headed

NTRK Gene Fusions in Solid Tumor Malignancies

Precision Medicine: Identifying Actionable Biomarkers

Detecting NTRK Gene Fusions

TRK Inhibitors for Solid Tumors: Overview

Larotrectinib for Solid Tumors With NTRK Gene Fusions

Entrectinib as Treatment for NTRK-Positive Solid Tumors

Managing Patients on TRK Inhibitors

Genomic Testing: GI Tumors

Genomic Testing: Sarcoma, Lung Cancer and Thyroid Cancer

Precision Medicine in Oncology: Overcoming Obstacles